Treatment of hepatitis C virus infection after renal transplantatio: New insights

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 8, 2000, Pages 74-76

  Rostaing, Lionel ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMANTADINE; CYCLOSPORIN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; LIVER ENZYME; RIBAVIRIN; STEROID; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG SAFETY; EUROPE; GRAFT REJECTION; HEMODIALYSIS; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PREVALENCE; PRIORITY JOURNAL; TH1 CELL;

HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION;

EID: 0034487572     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. National surveillance of hemodialysis associated diseases in the United States 1992
2. Trends in incidence of hepatitis C (HCV) infection in hemodialysis (HD) units
3. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: A need for new dialysis strategies
4. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications
5. Should the hepatitis C positive end stage renal disease patient be transplanted?
6. A prospective study of hepatitis C virus infection in renal allograft recipients
7. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years
8. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients
9. Impact of hepatitis B and C virus on kidney transplantation outcome
10. Glomerular diseases in patients with hepatitis C virus infection after renal transplantation
11. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients
12. Effect of renal transplantation on patient survival in anti-HCV positive patients
13. Randomised, double-blind, placebo controlled trial of interferon α-2b with or without ribavirin for chronic hepatitis C
14. Chronic viral hepatitis. Benefits of current therapies
15. Adverse effect of low-dose prophylactic human recombinant interferon-α treatment in renal transplant recipients
16. Low-dose-recombinant leukocyte interferon-α treatment of hepatitis C viral infection in renal transplant recipients
17. Interferon-α-induced acute renal allograft rejection
18. Acute renal failure in kidney transplant patients treated with interferon α2b for chronic hepatitis C
19. Recombinant α-interferon in renal allograft recipients with chronic hepatitis C
20. Exacerbation of glomerulo-nephritis in subjects with chronic hepatitis C virus infection after interferon therapy
21. Interferon-α (IFN) therapy in haemodialysis patients (HD) with associated hepatitis C virus infection (HCV): Influence of the Th1 and Th2 balance using intracellular cytokines analysis
22. Treatment of hepatitis C virus infection with ribavirin in kidney transplant patients
23. Treatment of chronic hepatitis C with amantadine
24. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon α non-responders
25. Long-term outcome of hepatitis C infection after liver transplantation
26. Measurement of intracellular cytokines
27. Pharmacokinetics of α-IFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis with normal renal function: Clinical implications
28. Interferon treatment for chronic hepatitis C virus infection in uremic patients
29. Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients
30. High rate of hepatitis C virus clearance in hemodialysis patients after interferon-α therapy
31. Interferon-α-2b treatment of chronic hepatitis C in haemodialysis patients